- Home
- ATXS vs SIFY Comparison
ATXS vs SIFY Comparison
Compare ATXS & SIFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATXS | SIFY |
|---|---|---|
| Founded | 2008 | 1995 |
| Country | United States | India |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 732.4M | 844.3M |
| IPO Year | 2015 | 1999 |
Fundamental Metrics
Financial Performance| Metric | ATXS | SIFY |
|---|---|---|
| Price | $13.10 | $12.21 |
| Analyst Decision | Hold | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $24.33 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 47.4K |
| Earning Date | 11-12-2025 | 01-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $706,000.00 | ★ $466,559,277.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $13.07 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 9.09 |
| 52 Week Low | $3.56 | $2.81 |
| 52 Week High | $13.29 | $17.85 |
Technical Indicators
Market Signals| Indicator | ATXS | SIFY |
|---|---|---|
| Relative Strength Index (RSI) | 65.67 | 56.44 |
| Support Level | $12.64 | $11.90 |
| Resistance Level | $13.03 | $12.66 |
| Average True Range (ATR) | 0.19 | 0.63 |
| MACD | -0.02 | 0.09 |
| Stochastic Oscillator | 94.00 | 71.96 |
Price Performance
Historical ComparisonAbout ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About SIFY Sify Technologies Limited
Sify Technologies Ltd is a provider of corporate network services in India. It offers converged Information and Communication Technology (ICT) solutions comprising Network- Connectivity services, Data Center services and Digital Services which include Cloud and Managed services, Applications Integration services and Technology Integration services. The company operates in three segments; Network Connectivity services which consists of domestic data, international data, wholesale voice. Data Center Services which consists of co-location services, cross connects and other allied managed services. Digital Services which consists of Cloud and Managed Services, Network Managed Services, Applications Integration Services, Technology Integration Services. Key revenue is from Network.